| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/01/2004 | CN1524879A Anti endothelial cell element, genes encoding same and pharmaceutical uses thereof |
| 09/01/2004 | CN1524877A Construction and preparation of stroma cell derivative factor - 1ª‡ recombinant mutant |
| 09/01/2004 | CN1524874A E1A protein, its preparing process and combination of medicament comprising the protein |
| 09/01/2004 | CN1524871A Sekolamin saponin compound |
| 09/01/2004 | CN1524869A Method for extracting anticarcinogenesis polysaccharide composite AVDS from A.valvataD. and its use as medicament |
| 09/01/2004 | CN1524864A Bis phosphate, preparation and uses of its pharmaceutical preparations |
| 09/01/2004 | CN1524859A Phenoxazones, preparing process and pharmaceutical uses thereof |
| 09/01/2004 | CN1524850A Histone de-acetylase inhibitor, preparation and application of pharmaceutical preparations of the same |
| 09/01/2004 | CN1524581A Polymer micelle medicine-carrying system |
| 09/01/2004 | CN1524580A Carmustine slow-release tablet and its preparation method |
| 09/01/2004 | CN1524576A Composite thymus peptide with immunoregulation function |
| 09/01/2004 | CN1524556A San Er antibacterial injection medicine |
| 09/01/2004 | CN1524532A Antineoplastic effect of a group of cycloart-one triterpene compound |
| 09/01/2004 | CN1164760C Tenascin-C nucleic acid ligands |
| 09/01/2004 | CN1164610C Novel anti-tumor compound Intercedenside B from picolour zhuopianshen |
| 09/01/2004 | CN1164604C Acetamido lactose PEG glycoside and dimer with activity of resisting tumor metastasis |
| 09/01/2004 | CN1164603C 1,6-fructostrontium biphosphate compounds and their preparing process and medical application |
| 09/01/2004 | CN1164583C Separating preparing technology of gallo catechin and gallate |
| 09/01/2004 | CN1164334C Sustained release formulation of peptide |
| 09/01/2004 | CN1164309C Medicament for treating cancer |
| 09/01/2004 | CN1164294C Liver cancer resisting medicine |
| 09/01/2004 | CN1164282C Tumor-treating medicine and its praparation method |
| 09/01/2004 | CN1164281C Qibeifeian particles for treating cancer of lung and its preparing process |
| 09/01/2004 | CN1164261C Liposome preparation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5, 10-dione dimaleate |
| 08/31/2004 | US6784315 Stilbene derivative crystal and method for producing the same |
| 08/31/2004 | US6784291 Splice-region antisense composition and method |
| 08/31/2004 | US6784210 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis |
| 08/31/2004 | US6784198 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 08/31/2004 | US6784195 Extracellular signal regulated kinase (erk); anticancer agents and protein kinase inhibitors |
| 08/31/2004 | US6784188 Urea substituted imidazoquinolines |
| 08/31/2004 | US6784184 5-(arylsulfonyl)-,5-(arylsulfinyl), and 5-(arylsulfanyl)-thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase |
| 08/31/2004 | US6784174 Inhibitors of the production of cytokines such as tnf |
| 08/31/2004 | US6784173 Aromatic dicarboxylic acid derivatives |
| 08/31/2004 | US6784169 Metalloprotease inhibitor; antiinflamamtory agents; rheumatic disorders; cardiovascular disorders; controlling cell proliferation |
| 08/31/2004 | US6784167 17-beta-hydroxysteroid dehydrogenase-II inhibitors |
| 08/31/2004 | US6784157 Peptide activates dna binding of wild-type p53 or a p53 mutant containing a single amino acid substitution; a peptidomimetic consisting of four sequential amino acids from a negative regulatory region; anticarcinogenic, -tumor agents |
| 08/31/2004 | US6784155 Contacting hematopoietic cells with a stem cell proliferation stimulating amount of inprol or an opiate compound or a combination of inprol and an opiate compound |
| 08/31/2004 | US6784153 Identify molecules that can bind to organ or tissue specific markers and, therefore, can home to the organ or tissue; membrane dipeptidase (mdp)-binding homing molecule, which is a molecule that selectively homes to lung endothelium |
| 08/31/2004 | US6783977 Internal ribosome entry site and vector containing same |
| 08/31/2004 | US6783956 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 08/31/2004 | US6783955 Polynucleotides encoding human presenilin variant |
| 08/31/2004 | US6783935 Genetic polymorphism of MxA protein and use thereof |
| 08/31/2004 | US6783775 Comprising ceruloplasmin and a serum-derived composition (sdf) having a low molecular weight, electrically charged at acidic ph and having absorption at 280 mn, capable of inducing terminal cell differentiation of leukemic cells |
| 08/31/2004 | US6783771 Biologically active substance eem-sb obtained by extracting hypsizygus marmoreus with water, a lower alcohol having 1-4 and treating the extract using a molecular sieve method |
| 08/31/2004 | US6783761 Hormone inhibitors for inducing antibodies against gonadotropin-releasing hormone, comprises fusion peptide of helper t-cell peptide epitope and immunomimic peptide epitope |
| 08/31/2004 | US6783760 Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 08/31/2004 | US6783758 Diagnosis and treatment of malignant neoplasms |
| 08/31/2004 | US6783569 Vacuum vapor deposition; metallization, alloying |
| 08/31/2004 | US6782891 Process for the isolation of a major harmful oxidant from cigarette smoke |
| 08/31/2004 | CA2194369C Methods and compositions for the specific coagulation of vasculature |
| 08/31/2004 | CA2133429C Topical administration of toremifene and its metabolites |
| 08/27/2004 | CA2458001A1 Regulation of immune responses by manipulation of intermediary metabolite levels |
| 08/26/2004 | WO2004072284A1 Modulation of insulin like growth factor i receptor expression |
| 08/26/2004 | WO2004072257A2 Dyrks as modifiers of the apc and axin pathways and methods of use |
| 08/26/2004 | WO2004072117A2 Antibodies to c-met for the treatment of cancers |
| 08/26/2004 | WO2004072113A1 Method and compositions for boosting immune response |
| 08/26/2004 | WO2004072110A1 Methods for inhibiting signal transduction |
| 08/26/2004 | WO2004072092A1 Medicament for inhibiting tumour growth |
| 08/26/2004 | WO2004072081A1 Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity |
| 08/26/2004 | WO2004072080A1 Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of hsp90 complex activity |
| 08/26/2004 | WO2004072078A1 Pyrazolotriazine derivatives, methods for production and uses thereof |
| 08/26/2004 | WO2004072070A1 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives |
| 08/26/2004 | WO2004072063A1 Heteroaryl substituted pyrolls useful as inhibitors of protein kinases |
| 08/26/2004 | WO2004072056A1 Medicinal composition |
| 08/26/2004 | WO2004072051A1 Isoxazole compounds as inhibitors of heat shock proteins |
| 08/26/2004 | WO2004072049A1 Polymorph of {6,7-bis(2-methoxy-ethoxy)-quinazolin-4-yl}-(3e) |
| 08/26/2004 | WO2004072047A1 Indoles, benzimidazoles or naphhimidazoles as histone deacetylase (hdac) inhibitors |
| 08/26/2004 | WO2004072033A2 Pyrazoles and methods of making and using the same |
| 08/26/2004 | WO2004072027A2 Chemical derivatives binding very specifically with g-quadruplex dna structures and use thereof as a specific anti-cancer agent |
| 08/26/2004 | WO2004071530A2 Identification of cellular polypeptides differentially expressed by tumor cells |
| 08/26/2004 | WO2004071529A2 Uses of anti-insulin-like growth factor i receptor antibodies |
| 08/26/2004 | WO2004071525A1 Methods for treating mammary gland disorders |
| 08/26/2004 | WO2004071518A1 Remedy for cancer |
| 08/26/2004 | WO2004071507A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 08/26/2004 | WO2004071506A1 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 08/26/2004 | WO2004071505A2 Radiolabelled d-amino acids for use in diagnosis with spect and pet and systemic radionuclide therapy |
| 08/26/2004 | WO2004071458A2 REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS |
| 08/26/2004 | WO2004071457A2 Improved heat shock protein-based vaccines and immunotherapies |
| 08/26/2004 | WO2004071441A2 Compositions and methods to modulate immune and inflammatory responses |
| 08/26/2004 | WO2004071400A2 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity |
| 08/26/2004 | WO2004071397A2 Combination therapy of zd6474 with 5-fu or/and cpt-11 |
| 08/26/2004 | WO2004071382A2 Substituted heterocycles |
| 08/26/2004 | WO2004071378A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 08/26/2004 | WO2004063336A3 Uses of deazapurines for the treatment of reperfusion injuries, osteoporosis and/or bone metastasis |
| 08/26/2004 | WO2004058766A3 Tumour-inhibiting annellated azepinone derivatives |
| 08/26/2004 | WO2004056991A3 Novel angiogenic molecular target and uses thereof |
| 08/26/2004 | WO2004045611A8 Use of a thiazolidinedione for the reduction of side effects of chemotherapy |
| 08/26/2004 | WO2004044163A9 Methods for identifying risk of melanoma and treatments thereof |
| 08/26/2004 | WO2004034023A3 Methods of synthesizing 3-amino-1,2,4-benzotriazines |
| 08/26/2004 | WO2004018684A3 T-cell epitopes in staphylococcal enterotoxin b |
| 08/26/2004 | WO2004013310A3 Methods of down regulating target gene expression in vivo by introduction of interfering rna |
| 08/26/2004 | WO2004011464A3 Novel substituted pyrazolo[1,5 a]-1,3,5-triazine derivatives and their analogues, pharmaceutical compositions containing same, use thereof as medicine and methods for preparing same |
| 08/26/2004 | WO2004004653A3 Methods for treating psychosis associated with interferon-alpha therapy |
| 08/26/2004 | WO2004002431A3 Humanized anti-lymphotoyin beta receptor antibodies |
| 08/26/2004 | WO2003103585A3 Methods of treating angiogenesis, tumor growth, and metastasis |
| 08/26/2004 | WO2003092602A3 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 08/26/2004 | WO2003090681A3 SYNERGISTIC EFFECTS OF NUCLEAR TRANSCRIPTION FACTOR NF-κB INHIBITORS AND ANTI-NEOPLASTIC AGENTS |
| 08/26/2004 | WO2003087296A3 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells |
| 08/26/2004 | WO2003070911A3 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r) |
| 08/26/2004 | WO2002030268A3 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |